Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
31.48
-2.03 (-6.06%)
Sep 23, 2026, 11:16 AM EDT - Market open
Celldex Therapeutics Employees
Celldex Therapeutics had 198 employees as of December 31, 2025. The number of employees increased by 12 or 6.45% compared to the previous year.
Employees
198
Change (1Y)
12
Growth (1Y)
6.45%
Revenue / Employee
$798
Profits / Employee
-$1,517,924
Market Cap
2.47B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 198 | 12 | 6.45% | 198 | 0 |
| Dec 31, 2024 | 186 | 26 | 16.25% | 186 | 0 |
| Dec 31, 2023 | 160 | 12 | 8.11% | 160 | 0 |
| Dec 31, 2022 | 148 | 14 | 10.45% | 148 | 0 |
| Dec 31, 2021 | 134 | 9 | 7.20% | 132 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Arcus Biosciences | 601 |
| Denali Therapeutics | 507 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 289 |
| Immunome | 247 |
| uniQure | 221 |
| Disc Medicine | 165 |
CLDX News
- 1 hour ago - Celldex price target raised to $88 from $70 at Leerink - TheFly
- 4 hours ago - Celldex price target raised to $57 from $50 at Morgan Stanley - TheFly
- 23 hours ago - Celldex falls -11.4% - TheFly
- 23 hours ago - Celldex price target raised to $64 from $42 at H.C. Wainwright - TheFly
- 1 day ago - Celldex falls -5.1% - TheFly
- 1 day ago - Celldex Therapeutics Transcript: Study result - Transcripts
- 1 day ago - Celldex Therapeutics Press release: Study result - Filings
- 1 day ago - Celldex Therapeutics Slides: Study result - Filings